Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-May-24 5:44 PM View:  | Joshi Mehul Chief Financial Officer & PAO | Pulmonx Corp (LUNG) | 06-May-24 | Grant | 125,870 | -- | -- | 100% 0 to 125.87K | |
| 24-Apr-24 6:14 PM View: | Rose Geoffrey Beran Chief Commercial Officer | Pulmonx Corp (LUNG) | 22-Apr-24 | Sale (Planned) | 1,184 | $7.49 | $8,868.16 | (< 1%) 307.87K to 306.68K | |
| 26-Mar-24 5:53 PM View: | Rose Geoffrey Beran Chief Commercial Officer | Pulmonx Corp (LUNG) | 22-Mar-24 | Sale (Planned) | 1,184 | $9.36 | $11,082.20 | (< 1%) 309.05K to 307.87K | |
| 19-Mar-24 6:21 PM View: | Williamson Steve S PRESIDENT AND CEO Director | Pulmonx Corp (LUNG) | 15-Mar-24 | Grant | 205,286 | -- | -- | 100% 0 to 205.29K | |
| 05-Mar-24 6:18 PM View: | Lehman David Aaron General Counsel | Pulmonx Corp (LUNG) | 01-Mar-24 | Grant | 34,500 | -- | -- | 23% 149.84K to 184.34K | |
| 05-Mar-24 6:15 PM View: | French Glendon E. III President and CEO Director | Pulmonx Corp (LUNG) | 01-Mar-24 | Sale | 6,954 | $9.06 | $63,003.20 | (< 1%) 1.12M to 1.12M | |
| 05-Mar-24 6:22 PM View: | Rose Geoffrey Beran Chief Commercial Officer | Pulmonx Corp (LUNG) | 01-Mar-24 | Grant | 34,500 | -- | -- | 14% 243.05K to 277.55K | |
| 05-Mar-24 6:20 PM View: | McKune John Interim CFO | Pulmonx Corp (LUNG) | 01-Mar-24 | Grant | 14,400 | -- | -- | 30% 48.49K to 62.89K | |
| 05-Mar-24 6:18 PM View: | Lehman David Aaron General Counsel | Pulmonx Corp (LUNG) | 01-Mar-24 | Sale | 4,351 | $9.06 | $39,420.10 | (2%) 184.34K to 179.99K | |
| 05-Mar-24 6:20 PM View: | McKune John Interim CFO | Pulmonx Corp (LUNG) | 01-Mar-24 | Sale | 1,078 | $9.06 | $9,766.68 | (2%) 62.89K to 61.81K | |
| 05-Mar-24 6:22 PM View: | Rose Geoffrey Beran Chief Commercial Officer | Pulmonx Corp (LUNG) | 01-Mar-24 | Sale | 3,097 | $9.06 | $28,058.80 | (1%) 277.55K to 274.45K | |
| 26-Feb-24 6:23 PM View: | Rose Geoffrey Beran Chief Commercial Officer | Pulmonx Corp (LUNG) | 22-Feb-24 | Sale (Planned) | 1,184 | $14.20 | $16,812.80 | (< 1%) 244.23K to 243.05K | |
| 16-Feb-24 7:11 PM View: | French Glendon E. III President and CEO Director | Pulmonx Corp (LUNG) | 15-Feb-24 | Sale (Planned) | 20,000 | $14.60 | $292,000.00 | (2%) 1.14M to 1.12M | |
| 24-Jan-24 5:41 PM View: | Rose Geoffrey Beran Chief Commercial Officer | Pulmonx Corp (LUNG) | 22-Jan-24 | Sale (Planned) | 1,184 | $13.13 | $15,545.90 | (< 1%) 245.42K to 244.23K | |
| 22-Jan-24 6:05 PM View: | French Glendon E. III President and CEO Director | Pulmonx Corp (LUNG) | 18-Jan-24 | Sale (Planned) | 10,000 | $12.77 | $127,700.00 | (< 1%) 1.15M to 1.14M | |
| 27-Dec-23 4:19 PM View: | Rose Geoffrey Beran Chief Commercial Officer | Pulmonx Corp (LUNG) | 22-Dec-23 | Sale (Planned) | 1,184 | $12.75 | $15,096.00 | (< 1%) 246.6K to 245.42K | |
| 22-Dec-23 6:12 PM View: | French Glendon E. III President and CEO Director | Pulmonx Corp (LUNG) | 21-Dec-23 | Sale (Planned) | 10,000 | $12.42 | $124,200.00 | (< 1%) 1.16M to 1.15M | |
| 05-Dec-23 5:46 PM View: | Rose Geoffrey Beran Chief Commercial Officer | Pulmonx Corp (LUNG) | 01-Dec-23 | Sale | 2,868 | $10.34 | $29,655.10 | (1%) 249.47K to 246.6K | |
| 05-Dec-23 5:44 PM View: | McKune John Interim CFO | Pulmonx Corp (LUNG) | 01-Dec-23 | Grant | 7,233 | -- | -- | 17% 41.36K to 48.59K | |
| 05-Dec-23 5:42 PM View: | Lehman David Aaron General Counsel | Pulmonx Corp (LUNG) | 01-Dec-23 | Sale | 3,809 | $10.34 | $39,381.00 | (2%) 153.65K to 149.84K | |
| 05-Dec-23 5:41 PM View: | French Glendon E. III President and CEO Director | Pulmonx Corp (LUNG) | 01-Dec-23 | Sale | 6,676 | $10.34 | $69,029.80 | (< 1%) 1.17M to 1.16M | |
| 05-Dec-23 5:44 PM View: | McKune John Interim CFO | Pulmonx Corp (LUNG) | 01-Dec-23 | Sale | 942 | $10.34 | $9,738.93 | (2%) 48.59K to 47.65K | |
| 27-Nov-23 6:14 PM View: | Rose Geoffrey Beran Chief Commercial Officer | Pulmonx Corp (LUNG) | 22-Nov-23 | Sale (Planned) | 1,184 | $10.60 | $12,550.40 | (< 1%) 250.65K to 249.47K | |
| 25-Oct-23 6:20 PM View: | Rose Geoffrey Beran Chief Commercial Officer | Pulmonx Corp (LUNG) | 23-Oct-23 | Sale (Planned) | 1,184 | $8.35 | $9,886.40 | (< 1%) 251.84K to 250.65K | |
| 26-Sep-23 6:15 PM View: | Rose Geoffrey Beran Chief Commercial Officer | Pulmonx Corp (LUNG) | 22-Sep-23 | Sale (Planned) | 1,184 | $10.51 | $12,443.80 | (< 1%) 253.02K to 251.84K | |
| 06-Sep-23 6:07 PM View: | Sung Derrick Chief Financial Officer | Pulmonx Corp (LUNG) | 01-Sep-23 | Sale | 4,219 | $10.00 | $42,201.00 | (1%) 395.26K to 391.04K | |
| 06-Sep-23 5:52 PM View: | Lehman David Aaron General Counsel | Pulmonx Corp (LUNG) | 01-Sep-23 | Sale | 3,772 | $10.01 | $37,757.70 | (2%) 157.42K to 153.65K | |
| 06-Sep-23 5:50 PM View: | French Glendon E. III President and CEO Director | Pulmonx Corp (LUNG) | 01-Sep-23 | Sale | 6,527 | $10.01 | $65,335.30 | (< 1%) 1.17M to 1.17M | |
| 06-Sep-23 6:03 PM View: | Rose Geoffrey Beran Chief Commercial Officer | Pulmonx Corp (LUNG) | 01-Sep-23 | Sale | 2,843 | $10.01 | $28,458.40 | (1%) 255.86K to 253.02K | |
| 25-Aug-23 5:40 PM View: | Rose Geoffrey Beran Chief Commercial Officer | Pulmonx Corp (LUNG) | 23-Aug-23 | Sale (Planned) | 1,184 | $10.54 | $12,479.40 | (< 1%) 257.05K to 255.86K | |
| 24-Jul-23 6:30 PM View: | French Glendon E. III President and CEO Director | Pulmonx Corp (LUNG) | 20-Jul-23 | Sale (Planned) | 15,000 | $12.68 | $190,200.00 | (1%) 1.19M to 1.17M | |
| 02-Jun-23 6:51 PM View: | Sung Derrick Chief Financial Officer | Pulmonx Corp (LUNG) | 01-Jun-23 | Sale | 4,222 | $11.49 | $48,506.80 | (1%) 399.48K to 395.26K | |
| 02-Jun-23 6:31 PM View: | Florin Daniel P Director | Pulmonx Corp (LUNG) | 01-Jun-23 | Grant | 12,620 | -- | -- | 44% 28.92K to 41.54K | |
| 02-Jun-23 6:47 PM View: | Rose Geoffrey Beran Chief Commercial Officer | Pulmonx Corp (LUNG) | 01-Jun-23 | Sale | 2,845 | $11.48 | $32,660.60 | (1%) 259.89K to 257.05K | |
| 02-Jun-23 6:40 PM View: | Lehman David Aaron General Counsel | Pulmonx Corp (LUNG) | 01-Jun-23 | Sale | 3,776 | $11.48 | $43,348.50 | (2%) 161.2K to 157.42K | |
| 02-Jun-23 6:48 PM View: | Sullivan Tiffany Director | Pulmonx Corp (LUNG) | 01-Jun-23 | Grant | 12,620 | -- | -- | 124% 10.21K to 22.83K | |
| 02-Jun-23 6:45 PM View: | Melenikiotou Georgia Director | Pulmonx Corp (LUNG) | 01-Jun-23 | Grant | 12,620 | -- | -- | 36% 34.73K to 47.34K | |
| 02-Jun-23 6:42 PM View: | Lynch Alissa Hsu Director | Pulmonx Corp (LUNG) | 01-Jun-23 | Grant | 12,620 | -- | -- | 106% 11.91K to 24.53K | |
| 02-Jun-23 6:29 PM View: | Ferrari Richard M Director | Pulmonx Corp (LUNG) | 01-Jun-23 | Grant | 12,620 | -- | -- | 42% 30.04K to 42.66K | |
| 02-Jun-23 6:24 PM View: | Mead Dana G Jr Director | Pulmonx Corp (LUNG) | 01-Jun-23 | Grant | 12,620 | -- | -- | 33% 38.8K to 51.42K | |
| 02-Jun-23 6:38 PM View: | French Glendon E. III President and CEO Director | Pulmonx Corp (LUNG) | 01-Jun-23 | Sale | 6,533 | $11.48 | $75,009.20 | (< 1%) 1.21M to 1.2M | |
| 02-Jun-23 6:27 PM View: | Burns Thomas William Director | Pulmonx Corp (LUNG) | 01-Jun-23 | Grant | 12,620 | -- | -- | 150% 8.41K to 21.03K | |
| 03-Mar-23 10:00 PM View: | Rose Geoffrey Beran Chief Commercial Officer | Pulmonx Corp (LUNG) | 01-Mar-23 | Grant | 78,900 | -- | -- | 43% 182.2K to 261.1K | |
| 03-Mar-23 10:00 PM View: | Lehman David Aaron General Counsel | Pulmonx Corp (LUNG) | 01-Mar-23 | Grant | 118,300 | -- | -- | 268% 44.16K to 162.46K | |
| 03-Mar-23 10:00 PM View: | French Glendon E. III President and CEO Director | Pulmonx Corp (LUNG) | 01-Mar-23 | Sale | 2,895 | $11.03 | $31,931.80 | (< 1%) 1.21M to 1.21M | |
| 03-Mar-23 10:00 PM View: | Sung Derrick Chief Financial Officer | Pulmonx Corp (LUNG) | 01-Mar-23 | Sale | 1,264 | $11.03 | $13,941.90 | (< 1%) 400.75K to 399.48K | |
| 03-Mar-23 10:00 PM View: | French Glendon E. III President and CEO Director | Pulmonx Corp (LUNG) | 01-Mar-23 | Grant | 173,500 | -- | -- | 17% 1.04M to 1.21M | |
| 03-Mar-23 10:00 PM View: | Rose Geoffrey Beran Chief Commercial Officer | Pulmonx Corp (LUNG) | 01-Mar-23 | Sale | 1,206 | $11.03 | $13,302.20 | (< 1%) 261.1K to 259.89K | |
| 03-Mar-23 10:00 PM View: | Lehman David Aaron General Counsel | Pulmonx Corp (LUNG) | 01-Mar-23 | Sale | 1,264 | $11.03 | $13,941.90 | (< 1%) 162.46K to 161.2K | |
| 03-Mar-23 10:00 PM View: | Sung Derrick Chief Financial Officer | Pulmonx Corp (LUNG) | 01-Mar-23 | Grant | 138,000 | -- | -- | 53% 262.75K to 400.75K |
